Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

House Medicare bill retains Rep. Thomas' investigational device payment language.

This article was originally published in The Gray Sheet

Executive Summary

HOUSE MEDICARE BILL RETAINS REP. THOMAS' INVESTIGATIONAL DEVICE PROVISION after the House Rules Committee decided Oct. 18 to disallow broader language providing Medicare reimbursement for all investigational devices with an approved investigational device exemption. The Medicare reform bill passed by the House Oct. 19 reverts to language introduced by Rep. William Thomas (R-Calif.) in June (HR 1744) and subsequently incorporated into the original draft of the House Medicare bill. The final House measure would allow Medicare coverage of investigational devices only if the device has an approved IDE and is used in place of an approved device.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT004887

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel